key: cord-0894778-srhl3fxs
authors: Sharma, Priyanka; Gupta, Ravinder; Mahajan, Vikas
title: Multisystem Inflammatory Syndrome Presenting as Sinus Bradycardia in a Neonate with Prenatal Exposure to COVID-19
date: 2022-05-23
journal: Indian J Pediatr
DOI: 10.1007/s12098-022-04191-3
sha: d30b465692751ed4575fdc11d7754b1c4d7558a6
doc_id: 894778
cord_uid: srhl3fxs

nan

To the Editor: Multisystem inflammatory syndrome in children (MIS-C), with active or recent COVID-19 infection, has been increasingly reported. COVID-19-associated MIS-C-like disease has not been well described in neonates [1, 2] . Here, we report a rare case of multisystem inflammatory syndrome with cardiac involvement in a neonate (MIS-N) following COVID-19 disease during pregnancy. A baby born to a mother who was COVID-19-positive at 24 wk of pregnancy with minimal symptoms, and delivered at 38 wk with severe respiratory distress requiring ventilation developed bradycardia with HR 50-60 beats/min and hypotension at 36 h of age. ECG showed sinus bradycardia with no evidence of block, echocardiogram -EF of 40% and no coronary involvement, elevated troponin T -0.23 ng/mL (0-0.1 ng/mL), CRP -2.77 mg/d (0-0.8 mg/dL), serum ferritin -149.5 ng/mL (25-200 ng/mL), D-dimer -3.12 µ/mL (0.22-0.46 µg/mL), and SARS-CoV-2 IgG antibody positive (75.91 Au/mL). Maternal SARS-CoV-2 IgG antibody was also reactive (82.70 Au/mL) with raised serum ferritin -164.1 ng/mL and D-dimer -0.62 ng/mL; SARS-CoV-2 RT-PCR was negative in both mother and baby. Septic workup and electrolytes were normal. Considering the possibility of neonatal MIS-C with cardiac involvement, dobutamine (10 µg/kg/min), intravenous immunoglobulin (1 g/kg/dose), and hydrocortisone (0.5 mg/kg every 12 h for 2 d) were administered. Marked improvement was seen with normal HR after 6 h of above management; extubated on day 5, and discharged after 2 wk. Repeat echocardiography on day 14 showed normal cardiac function. Cardiac and inflammatory markers also improved gradually.

This case adds to the growing evidence pointing to the potentially devastating but treatable neonatal outcomes.

Bradycardia as the manifestation of neonatal MIS-C has not been documented in the literature. This is the peculiarity of the index case [3] . Currently, we are recovering from the third wave of SARS-CoV-2 transmission and expect that a significant percentage of mothers were affected during pregnancy; so, we should consider the possibility of MIS-N.

Neonatal early-onset infection with SARS-CoV-2 in 33 neonates born to mothers with COVID-19 in Wuhan, China

COVID-19: current understanding of its pathophysiology, clinical presentation and treatment

Cardiac manifestations in SARS-CoV-2-associated multisystem inflammatory syndrome in children: a comprehensive review and proposed clinical approach